Author:
Bénard-Laribière Anne,Noize Pernelle,Pambrun Elodie,Bazin Fabienne,Verdoux Hélène,Tournier Marie,Bégaud Bernard,Pariente Antoine
Funder
Agence Nationale de Sécurité du Médicament et des produits de santé
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology,General Medicine
Reference38 articles.
1. Agence Nationale de Sécurité du Médicament et des produits de santé (2012) Etat des lieux de la consommation des benzodiazépines en France. http://ansm.sante.fr/S-informer/Points-d-information-Points-d-information/Etat-des-lieux-en-2013-de-la-consommation-des-benzodiazepines-en-France-Point-d-Information . Accessed 11 Nov 2015
2. Huerta C, Abbing-Karahagopian V, Requena G, Oliva B, Alvarez Y, Gardarsdottir H, Miret M, Schneider C, Gil M, Souverein PC, De Bruin ML, Slattery J, De Groot MC, Hesse U, Rottenkolber M, Schmiedl S, Montero D, Bate A, Ruigomez A, Garcia-Rodriguez LA, Johansson S, de Vries F, Schlienger RG, Reynolds RF, Klungel OH, de Abajo FJ (2015) Exposure to benzodiazepines (anxiolytics, hypnotics and related drugs) in seven European electronic healthcare databases: a cross-national descriptive study from the PROTECT-EU Project. Pharmacoepidemiol Drug Saf. doi: 10.1002/pds.3825
3. Clay E, Falissard B, Moore N, Toumi M (2013) Contribution of prolonged-release melatonin and anti-benzodiazepine campaigns to the reduction of benzodiazepine and Z-drugs consumption in nine European countries. Eur J Clin Pharmacol 69(4):1–10. doi: 10.1007/s00228-012-1424-1
4. Alessi-Severini S, Bolton JM, Enns MW, Dahl M, Collins DM, Chateau D, Sareen J (2014) Use of benzodiazepines and related drugs in Manitoba: a population-based study. CMAJ Open 2(4):E208–E216. doi: 10.9778/cmajo.20130076
5. Olfson M, King M, Schoenbaum M (2015) Benzodiazepine use in the United States. JAMA Psychiatry 72(2):136–142. doi: 10.1001/jamapsychiatry.2014.1763
Cited by
36 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献